Browse 24914 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
June 17th, 2024 |
Ryan White HIV/AIDS Program Part C Early Intervention Services Program: Existing Geographic Service Areas |
Health Resources and Services Administration |
June 17th, 2024 |
Ryan White HIV/AIDS Program Part C Early Intervention Services Program: Existing Geographic Service Areas |
Health Resources and Services Administration |
June 17th, 2024 |
Ryan White HIV/AIDS Program Part C Early Intervention Services Program: Existing Geographic Service Areas |
Health Resources and Services Administration |
April 26th, 2025 |
Private Sector Collaboration Pathway (PSCP) Jordan Addendum |
Jordan USAID Amman |
August 15th, 2024 |
Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance Use and Mental Health Disorders (R01 Clinical Trial Required) |
National Institutes of Health |
May 17th, 2024 |
Request For Information-Local Works Mozambique |
Mozambique USAID Maputo |
October 4th, 2024 |
Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
April 8th, 2027 |
NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
November 19th, 2024 |
Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required) |
National Institutes of Health |
November 5th, 2024 |
Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Amyloid Beta Immunotherapy (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
September 29th, 2027 |
Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education Experiences and/or Mentoring Networks (R25- Independent Clinical Trial Not Allowed) |
National Institutes of Health |
June 10th, 2024 |
Fiscal Year (FY) 2025 Quality Improvement Fund - Transitions in Care for Justice-Involved Populations (QIF-TJI) |
Health Resources and Services Administration |
December 18th, 2024 |
Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed) |
National Institutes of Health |
May 6th, 2027 |
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic Experimental Studies with Humans Required) |
National Institutes of Health |
May 6th, 2027 |
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
May 6th, 2027 |
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) |
National Institutes of Health |
May 20th, 2024 |
Kenya Digital Health Ecosystem |
Kenya USAID Nairobi |
July 30th, 2024 |
Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 6th, 2024 |
USAID Kitumaini |
Democratic Republic of the Congo USAID Kinshasa |
June 8th, 2024 |
Achieving Global Health Security Through Strengthening Public Health Emergency Preparedness and Management Platforms in Liberia |
Centers for Disease Control GHC |
|
June 9th, 2024 |
Public Health Partnerships to Accelerate Prevention and Control of Infectious Diseases and Emerging Public Health Threats in China and Globally |
Centers for Disease Control GHC |
October 4th, 2024 |
Mechanistic and Hemodynamic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
June 5th, 2024 |
Advancing Diagnostic Network Optimization, Stepwise Laboratory Accreditation, and Integrated One Health Specimen Transport in Liberia |
Centers for Disease Control GHC |
July 22nd, 2024 |
Single Source for the Continuation of the Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed) |
National Institutes of Health |
June 27th, 2024 |
Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) |
National Institutes of Health |
May 6th, 2024 |
USAID Usalama wa Afya Duniani (Global Health Security) Project |
Tanzania USAID Dar es Salaam |
October 18th, 2024 |
Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
July 30th, 2024 |
Medical Rehabilitation Research Resource (P50 Clinical Trial Optional) |
National Institutes of Health |
June 2nd, 2026 |
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
June 15th, 2025 |
Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed) |
National Institutes of Health |
May 3rd, 2024 |
USAID Kenya and East Africa (KEA) Social and Behavior Change (SBC) Activity |
Kenya USAID Nairobi |
January 7th, 2027 |
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) |
National Institutes of Health |
August 13th, 2024 |
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2027 |
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) |
National Institutes of Health |
July 17th, 2024 |
Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial Optional) |
National Institutes of Health |
August 20th, 2024 |
Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
August 9th, 2024 |
Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed) |
National Institutes of Health |
August 9th, 2024 |
Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
July 9th, 2024 |
Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 18th, 2024 |
Diabetes Research Centers (P30 Clinical Trial Optional) |
National Institutes of Health |